Willow Street Advisors’s AstraZeneca AZN Stock Holding History

Willow Street Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$517K	Hold	8,700	–	–	0.29%	94
2013 Q3	$452K	Hold	8,700	–	–	0.28%	98
2013 Q2	$412K	Buy	+8,700	New	+$443K	0.26%	106

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Willow Street Advisors's AZN Position: Q4 2013 in Review

Willow Street Advisors held its AstraZeneca (AZN) position steady in Q4 2013 at 8,700 shares worth $517K. The position accounts for 0.29% of the portfolio, ranked #94.

Willow Street Advisors first reported a position in AZN in Q2 2013 and has held it in 3 quarters since. 379 funds tracked by Wall St. Rank hold AZN as of Q4 2013.

Willow Street Advisors held 8,700 shares of AstraZeneca worth $517K as of Q4 2013.
Willow Street Advisors left its AstraZeneca share count unchanged in Q4 2013.
AstraZeneca made up 0.29% of Willow Street Advisors's portfolio in Q4 2013, its #94 holding.
Willow Street Advisors first reported a position in AstraZeneca in Q2 2013 and has held it in 3 quarters since.
379 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2013.

Based on Willow Street Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.